Login
$HQ
$14.48 -$0.26 (1.76%) Close

$HQ 4 SEC Filings

Filed On Filing
21 Oct 2026 Form 4: Fitzsimons Catherine Michele, CLO and CCO

Granted 601,932 Stock Option (Right to Buy) ($6.49M)

16 Sep 2026 Form 4: Chew Qian Yi Amanda, Chief Product Officer

Granted 17,857 Restricted Stock Unit

15 Sep 2026 Form 4: Fitzsimons Catherine Michele, CL and CO

Granted 34,372 Restricted Stock Unit · Received 2,148 shares by exercise or conversion · Returned 1,122 shares to the issuer ($17.1K) · 1 more

15 Sep 2026 Form 4: Gould Greg, Chief Financial Officer

Granted 54,995 Restricted Stock Unit · Received 3,437 shares by exercise or conversion · Returned 1,272 shares to the issuer ($19.4K) · 1 more

15 Sep 2026 Form 4: Tan Si-Hui, Chief Science Officer

Granted 55,000 Stock Option (Right to Buy) · Granted 91,659 Restricted Stock Unit · Received 3,600 shares as a grant or award · 3 more

15 Sep 2026 Form 4: Fitzsimons Joseph Francis, Director

Granted 229,148 Restricted Stock Unit · Received 14,321 shares by exercise or conversion · Returned 3,438 shares to the issuer ($52.3K) · 1 more

25 Mar 2026 Form 4: Lambert Danielle, Director

Bought 84,602 shares ($1M)

25 Mar 2026 Form 4: Tan Si-Hui, Chief Science Officer

Granted 500,000 Stock Option (Right to Buy)

25 Mar 2026 Form 4: Gould Greg, Chief Financial Officer

Granted 285,300 Stock Option (Right to Buy)

24 Mar 2026 Form 4: Fitzsimons Joseph Francis, Director

Received 19,744,585 shares as a grant or award

20 Mar 2026 Form 4: You Harry L., Director

Received 1,163,484 shares as a grant or award · Granted 2,884,660 Warrants

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support